Newcelx Ltd (NCEL)

Jun 15, 2026

NewcelX Stem Cell Platform Strengthened by Peer-Reviewed AstroRx Study in Multiple Sclerosis - TipRanks

Jun 15, 2026

Jun 15, 2026

Peer-reviewed AstroRx data underscore NewcelX (NCEL) stem cell platform - Stock Titan

Jun 15, 2026

Jun 13, 2026

Exclusive: NewcelX eyes accelerated 2026 execution for diabetes drug - MSN

Jun 13, 2026

Jun 05, 2026

NewcelX Calls June 30, 2026 Shareholders’ Meeting as 2025 Losses Deepen - TipRanks

Jun 05, 2026

Jun 04, 2026

NewcelX Stock Moves Up Ahead of FDA Meeting on Diabetes Treatment - Bez Kabli

Jun 04, 2026

Jun 01, 2026

Exclusive: NewcelX advances diabetes therapy toward human trials with FDA pre-IND submission - MSN

Jun 01, 2026

May 29, 2026

NCEL Should I Buy - Intellectia AI

May 29, 2026

May 28, 2026

NewcelX Ltd. (NCEL) Gains Ground: Testing Key Resistance LevelsStatistical Arbitrage - newsline.com

May 28, 2026

May 27, 2026

Newcelx submits pre-IND package for NCEL-101 to FDA - BioWorld News

May 27, 2026

May 27, 2026

NewcelX Files Pre-IND With FDA for NCEL-101 Type 1 Diabetes Cell Therapy - TipRanks

May 27, 2026

May 27, 2026

Newcelx submits pre-IND package to FDA for NCEL-101 for treatment of type 1 diabetes - marketscreener.com

May 27, 2026

May 27, 2026

NewcelX (Nasdaq: NCEL) files FDA pre-IND for NCEL-101 diabetes cell therapy - Stock Titan

May 27, 2026

May 27, 2026

NewcelX Ltd. Schedules Pre-IND Meeting with FDA to Propel Type 1 Diabetes Treatment NCEL-101 into First-In-Human Trials - Quiver Quantitative

May 27, 2026

May 27, 2026

Stem cell therapy targeting a potential type 1 diabetes cure nears trials - Stock Titan

May 27, 2026

May 22, 2026

NCEL Stock Price, Quote & Chart | NEWCELX LTD (NASDAQ:NCEL) - ChartMill

May 22, 2026

May 18, 2026

[EFFECT] NewcelX Ltd. SEC Filing - Stock Titan

May 18, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

NewcelX (NASDAQ: NCEL) registers 2.26M shares for resale by investors - Stock Titan

May 11, 2026

May 06, 2026

Why NewcelX (NCEL) is still under the radar (Risk Aversion) 2026-05-06Top Analyst Buy Signals - Newser

May 06, 2026

May 06, 2026

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares - Quantisnow

May 06, 2026

May 05, 2026

NewcelX Ltd. (NCEL) updates resale prospectus for up to 500,000 shares - Stock Titan

May 05, 2026

May 05, 2026

How NewcelX (NCEL) differentiates itself from competitors (Investor Concern) 2026-05-05High Interest Stocks - newser.com

May 05, 2026

May 04, 2026

Julien Ruggieri Discloses Investment at NewcelX Ltd. with 25.3% Stake - TradingView

May 04, 2026

May 04, 2026

League Jinn holds 25.3% ownership stake in NewcelX (NCEL) - Stock Titan

May 04, 2026

May 01, 2026

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - Yahoo Finance

May 01, 2026

May 01, 2026

NLSPW SEC FilingsNEWCELX LTD 10-K, 10-Q, 8-K Forms - Stock Titan

May 01, 2026

May 01, 2026

Olivier Samuel Buys Handful Of Shares In NewcelX - 富途牛牛

May 01, 2026

May 01, 2026

Despite NewcelX's Pullback, Insiders Still Gained ₪136k - Yahoo Finance

May 01, 2026

May 01, 2026

NewcelX Loses US$2.3m Market Value But Insiders See Windfall Of ₪136k - simplywall.st

May 01, 2026

Apr 30, 2026

NCEL | NewcelX Ltd. Ordinary Shares Insider Trading - Quiver Quantitative

Apr 30, 2026

Apr 30, 2026

NewcelX Ltd. announced that it has received $1.349994 million in funding - marketscreener.com

Apr 30, 2026

Apr 30, 2026

NCEL - Finviz

Apr 30, 2026

Apr 30, 2026

NewcelX Posts 2025 Results and Bolsters Funding to Accelerate Type 1 Diabetes Program - TipRanks

Apr 30, 2026

Apr 30, 2026

Newcelx Reports Financial Results for 2025 an - Moomoo

Apr 30, 2026

Apr 30, 2026

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 - The Manila Times

Apr 30, 2026

Apr 30, 2026

NewcelX and Eledon Pharmaceuticals Collaborate on NCEL-101 for Type 1 Diabetes, Reporting Strong Financial Position and Strategic Growth Plans - Quiver Quantitative

Apr 30, 2026

Apr 30, 2026

NewcelX makes Type 1 diabetes program its 2026 flagship - Stock Titan

Apr 30, 2026

Apr 29, 2026

Insider Buying: Olivier Samuel Acquires 81,818 Shares of NewcelX Ltd (NCEL) - GuruFocus

Apr 29, 2026

Apr 29, 2026

NewcelX Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Apr 29, 2026

Apr 29, 2026

NewcelX (NCEL) 20-F: Kadimastem merger, heavy losses and funding risk - Stock Titan

Apr 29, 2026

Apr 29, 2026

NewcelX Ltd. (NCEL) director buys shares and long-dated warrants - Stock Titan

Apr 29, 2026

Apr 27, 2026

NewcelX Ltd. (NCEL) Stock Price Today - MEXC Exchange

Apr 27, 2026

Apr 23, 2026

NewcelX (NCEL) Trend Analysis | Q1 2025: Earnings ReportDividend Report - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 21, 2026

NewcelX updates presentation on diabetes therapy collaboration By Investing.com - Investing.com India

Apr 21, 2026

Apr 20, 2026

Newcelx updates corporate presentation to highlight type 1 diabetes flagship program - marketscreener.com

Apr 20, 2026

Apr 20, 2026

NewcelX Highlights Type 1 Diabetes Flagship and Eledon Collaboration in Updated April 2026 Presentation - TipRanks

Apr 20, 2026